Capital World Investors Purchases Shares of 7,677,904 Ventas, Inc. $VTR

Capital World Investors purchased a new stake in Ventas, Inc. (NYSE:VTR) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 7,677,904 shares of the real estate investment trust’s stock, valued at approximately $594,116,000.

A number of other institutional investors have also modified their holdings of VTR. Bridgewater Advisors Inc. boosted its stake in Ventas by 2.0% during the 4th quarter. Bridgewater Advisors Inc. now owns 6,790 shares of the real estate investment trust’s stock worth $525,000 after purchasing an additional 133 shares during the period. True Wealth Design LLC boosted its stake in Ventas by 32.0% during the 4th quarter. True Wealth Design LLC now owns 569 shares of the real estate investment trust’s stock worth $44,000 after purchasing an additional 138 shares during the period. Cigna Investments Inc. New boosted its stake in Ventas by 3.3% during the 4th quarter. Cigna Investments Inc. New now owns 4,396 shares of the real estate investment trust’s stock worth $341,000 after purchasing an additional 142 shares during the period. Parallel Advisors LLC boosted its stake in Ventas by 4.6% during the 3rd quarter. Parallel Advisors LLC now owns 3,970 shares of the real estate investment trust’s stock worth $278,000 after purchasing an additional 175 shares during the period. Finally, HighTower Advisors LLC boosted its stake in Ventas by 0.4% during the 3rd quarter. HighTower Advisors LLC now owns 42,092 shares of the real estate investment trust’s stock worth $2,946,000 after purchasing an additional 182 shares during the period. 94.18% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

VTR has been the subject of several recent research reports. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $93.00 price target on shares of Ventas in a report on Monday, February 9th. Scotiabank raised their target price on Ventas from $93.00 to $95.00 and gave the company a “sector perform” rating in a report on Thursday, May 21st. JPMorgan Chase & Co. raised their target price on Ventas from $93.00 to $94.00 and gave the company an “overweight” rating in a report on Monday, May 11th. Weiss Ratings reissued a “buy (b-)” rating on shares of Ventas in a report on Friday, March 27th. Finally, Argus set a $88.00 target price on Ventas in a report on Tuesday, February 10th. Fourteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Ventas currently has a consensus rating of “Moderate Buy” and an average target price of $95.19.

Insider Buying and Selling at Ventas

In other news, Director Michael J. Embler purchased 2,500 shares of the business’s stock in a transaction dated Wednesday, June 3rd. The stock was acquired at an average price of $78.81 per share, with a total value of $197,025.00. Following the purchase, the director directly owned 19,202 shares of the company’s stock, valued at $1,513,309.62. This represents a 14.97% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Walter C. Rakowich sold 1,152 shares of Ventas stock in a transaction on Thursday, May 14th. The stock was sold at an average price of $90.20, for a total value of $103,910.40. Following the transaction, the director directly owned 28,349 shares of the company’s stock, valued at $2,557,079.80. This trade represents a 3.90% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.53% of the company’s stock.

Ventas Trading Up 0.1%

NYSE:VTR opened at $82.13 on Monday. The company has a market capitalization of $39.93 billion, a PE ratio of 149.33, a price-to-earnings-growth ratio of 1.81 and a beta of 0.71. The company has a quick ratio of 0.25, a current ratio of 0.25 and a debt-to-equity ratio of 0.95. Ventas, Inc. has a 52-week low of $61.76 and a 52-week high of $91.06. The stock has a fifty day simple moving average of $85.05 and a 200-day simple moving average of $82.39.

Ventas (NYSE:VTR) last released its quarterly earnings results on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.01). The firm had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.59 billion. Ventas had a return on equity of 2.09% and a net margin of 4.25%.The company’s quarterly revenue was up 22.0% compared to the same quarter last year. During the same period last year, the firm earned $0.84 EPS. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. On average, equities research analysts expect that Ventas, Inc. will post 3.88 earnings per share for the current fiscal year.

Ventas Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, July 16th. Stockholders of record on Tuesday, June 30th will be paid a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a dividend yield of 2.5%. The ex-dividend date of this dividend is Tuesday, June 30th. Ventas’s payout ratio is 378.18%.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.